Humana (HUM) Tops Q4 EPS by 8c, Offers Guidance

Humana (NYSE: HUM) reported Q4 EPS of $2.28, $0.08 better than the analyst estimate of $2.20. Revenue for the quarter came in at $16.3 billion versus the consensus estimate of $16.19 billion.

GUIDANCE:

Humana sees FY2020 EPS of $18.25-$18.75, versus the consensus of $18.63.

• FY 2020 EPS guidance in a range of $17.76 to $18.26 on a GAAP basis, $18.25 to $18.75 on an Adjusted basis
• Retail segment finished the year strong, with the segment benefit expense ratio 70 basis points better than the initial guidance midpoint, fueled by lower than expected utilization
• Reaffirmed expected FY 2020 individual Medicare Advantage membership growth of 270,000 to 330,000 members, representing 7.5 percent to 9.2 percent growth over 2019

For earnings history and earnings-related data on Humana (HUM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KeyBanc Upgrades Nucor (NUE) to Overweight
• Green Dot and CommerceOne shareholders approve acquisition deal